Opinion: A Modest Proposal to Address NIH Insanity
Opinion: A Modest Proposal to Address NIH Insanity
Silicon Valley’s early-stage funding model could address a dearth of opportunities for young investigators just launching new projects.
Opinion: A Modest Proposal to Address NIH Insanity
Opinion: A Modest Proposal to Address NIH Insanity

Silicon Valley’s early-stage funding model could address a dearth of opportunities for young investigators just launching new projects.

Silicon Valley’s early-stage funding model could address a dearth of opportunities for young investigators just launching new projects.

business
Researchers React to Microsoft’s Acquisition of GitHub
Researchers React to Microsoft’s Acquisition of GitHub
Anna Azvolinsky | Jun 7, 2018
Computational biologists are optimistic that the purchase of the world’s largest hub for open-source computer code will not affect the way they use GitHub for science.
MyHeritage Account Data Compromised in “Cybersecurity Incident”
MyHeritage Account Data Compromised in “Cybersecurity Incident”
Catherine Offord | Jun 6, 2018
A security researcher found the email addresses and encrypted passwords of more than 92 million users of the genealogy site on a private server outside the company.
Blue Rush: One Company Leads the Race to Own Marine Genetic Sequences
Blue Rush: One Company Leads the Race to Own Marine Genetic Sequences
Ruth Williams | Jun 6, 2018
Almost half of all patents relating to the genes of marine organisms belong to one large international corporation, BASF, a new study reveals.  
Companies to Help People Sell or Rent Out Their Health Data
Companies to Help People Sell or Rent Out Their Health Data
Catherine Offord | Jun 5, 2018
Luna DNA, Nebula Genomics, and other “bio-brokers” will allow customers to make money by granting access to their genetic and personal information for research purposes.
SEC Charges Theranos With Fraud
SEC Charges Theranos With Fraud
Jim Daley | Mar 14, 2018
The company raised more than $700 million based on false claims to investors, according to the complaint.
Severe Toxicity Reported in High-Dose AAV Gene Therapy in Animals
Severe Toxicity Reported in High-Dose AAV Gene Therapy in Animals
Jim Daley | Jan 31, 2018
Biotech stocks fell in response to the news. 
Should Healthy People Have Their Exomes Sequenced?
Should Healthy People Have Their Exomes Sequenced?
Ruth Williams | Mar 24, 2017
With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  
Johnson & Johnson to Acquire Swiss Biotech Firm for $30 Billion
Johnson & Johnson to Acquire Swiss Biotech Firm for $30 Billion
Joshua A. Krisch | Jan 27, 2017
With its purchase of Actelion, Johnson & Johnson’s acquires experimental treatments for pulmonary arterial hypertension and several rare diseases.
That Other CRISPR Patent Dispute
That Other CRISPR Patent Dispute
Kerry Grens | Aug 31, 2016
The Broad Institute and Rockefeller University disagree over which scientists should be named as inventors on certain patents involving the gene-editing technology.